<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02777970</url>
  </required_header>
  <id_info>
    <org_study_id>DEX-TRA-06</org_study_id>
    <nct_id>NCT02777970</nct_id>
  </id_info>
  <brief_title>Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar</brief_title>
  <acronym>DAVID</acronym>
  <official_title>Analgesic Efficacy of Oral Dexketoprofen Trometamol/Tramadol Hydrochloride Versus Tramadol Hydrochloride/Paracetamol: a Randomised, Double-blind, Placebo and Active-controlled, Parallel Group Study in Moderate to Severe Acute Pain After Removal of Impacted Lower Third Molar (Dexketoprofen Analgesic eVolution wIth tramaDol- DAVID Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Menarini Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Menarini Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is aimed to evaluate the analgesic efficacy of TRAM.HCl/DKP.TRIS 75mg/25mg oral
      fixed drug combination in comparison with TRAM.HCl /paracetamol 75mg/650mg in the treatment
      of moderate to severe acute pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present phase IV study is a randomised, double-blind, placebo and active-controlled,
      parallel group study in moderate to severe acute pain after removal of impacted lower third
      molar.

      In this single-dose clinical trial patients are randomized to the following 3 treatment arms
      in a 2:2:1 ratio:

        -  TRAM.HCL/DKP.TRIS

        -  Paracetamol/TRAM.HCL

        -  Placebo.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TOTPAR6 (Total Pain Relief)</measure>
    <time_frame>6 hours post-dose</time_frame>
    <description>TOTPAR calculated as the weighted sum of the PAR scores (measured according to a 5-point VRS (Verbal Rating Scale) from 0=no relief to 4=complete relief), over 6 hours post-dose (TOTPAR6).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>% of patients achieving 50% of max TOTPAR</measure>
    <time_frame>8 hours post-dose</time_frame>
    <description>Percentage of patients achieving at least 50% of maximum TOTPAR over 8 hours post-dose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of patients achieving 30% of PI (Pain Intensity) reduction over 8 hours post-dose</measure>
    <time_frame>8 hours post-dose</time_frame>
    <description>Percentage of patients who achieved at least 30% of PI reduction versus baseline at each pre-specified time point over the 8-hour post-dose period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to confirmed FPPAR (First Perceptible Pain Relief)</measure>
    <time_frame>2 hours post-dose</time_frame>
    <description>Time to confirmed FPPAR (time to onset of analgesia) - i.e. time to FPPAR if confirmed by experiencing Meaningful Pain Relief (MPAR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of patients requiring RM</measure>
    <time_frame>8 hours post-dose</time_frame>
    <description>Percentage of patients who required RM within the first over 8 hours post-dose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PGE (Patient Global Evaluation)</measure>
    <time_frame>8 hours postdose</time_frame>
    <description>PGE of the study medication (measured according to a five-point VRS from 1 = poor to 5 = excellent) at 8 hours post-dose or whenever the patient uses Rescue Medication (RM).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">640</enrollment>
  <condition>Acute Pain</condition>
  <arm_group>
    <arm_group_label>Tramadol/Dexketoprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One film-coated tablet of Tramadol Hydrochloride/Dexketoprofen Trometamol 75mg/25mg oral single-dose;
Two tablets of Placebo matching Tramadol Hydrochloride/Paracetamol 37.5mg/325mg oral single-dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tramadol/Paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two film-coated tablets of Tramadol Hydrochloride/Paracetamol 75 mg/650 mg [2 x 37.5mg/325mg] oral single dose;
One tablet of Placebo matching Tramadol Hydrochloride/Dexketoprofen Trometamol oral single dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One tablet of Placebo matching Tramadol Hydrochloride/Dexketoprofen Trometamol 75mg/25mg oral single dose;
Two tablets of Placebo matching Tramadol Hydrochloride/Paracetamol 37.5mg/325mg oral single dose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol Hydrochloride/Dexketoprofen Trometamol</intervention_name>
    <arm_group_label>Tramadol/Dexketoprofen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol Hydrochloride/Paracetamol</intervention_name>
    <arm_group_label>Tramadol/Paracetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Tramadol/Dexketoprofen</arm_group_label>
    <arm_group_label>Tramadol/Paracetamol</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patients aged more than 18 years. Females participating in the study
             must be either non-childbearing potential or routinely using an effective method of
             birth control resulting in a low failure rate.

          -  Scheduled for outpatient surgical extraction -under local anaesthesia of lower third
             molar teeth, with at least one partially impacted in the mandible requiring bone
             manipulation.

          -  Pain of at least moderate intensity in the first 4 hours after the end of surgery (NRS
             score ≥ 4).

        Exclusion Criteria:

          -  History of allergy or hypersensitivity to the study treatments, RM or to any other
             NSAIDs, opioids and acetyl salicylic acid.

          -  History of peptic ulcer, gastrointestinal disorders by NSAIDs or gastrointestinal
             bleeding or other active bleedings.

          -  History of any illness or condition that, in the opinion of the Investigator might
             pose a risk to the patient or confound the efficacy and safety results of the study.

          -  Patients using and not suitable for withdrawing the prohibited medications specified
             in the protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dr. Tóth Bagi Zoltán Fogászati Rendeloje</name>
      <address>
        <city>Budapest</city>
        <zip>1052</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OralMed Studio Fogászati és Szájsebészeti Kft.</name>
      <address>
        <city>Budapest</city>
        <zip>1126</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudományegyetem</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile San Salvatore di L'Aquila</name>
      <address>
        <city>L'Aquila</city>
        <zip>67100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Integrata</name>
      <address>
        <city>Verona</city>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ars-Dent</name>
      <address>
        <city>Bialystok</city>
        <zip>15-078</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gabinet Stomatologiczny Andrzej Wojtowicz AW Clinic</name>
      <address>
        <city>Warszawa</city>
        <zip>00-852</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charme Clinique Klinika Stomatologii</name>
      <address>
        <city>Warszawa</city>
        <zip>02-670</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Medico Teknon</name>
      <address>
        <city>Barcelona</city>
        <zip>08022</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Médico Quirúrgico de Conxo</name>
      <address>
        <city>La Coruna</city>
        <zip>15702</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidad de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Community Healthcare NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <zip>B4 6NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Wales</name>
      <address>
        <city>Cardiff</city>
        <zip>CF14 4XT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M15 6FH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals of North Midlands NHS Trust</name>
      <address>
        <city>Stoke on Trent</city>
        <zip>ST4 6QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2016</study_first_submitted>
  <study_first_submitted_qc>May 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2016</study_first_posted>
  <last_update_submitted>February 9, 2017</last_update_submitted>
  <last_update_submitted_qc>February 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute pain</keyword>
  <keyword>Acute moderate to severe pain</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Dexketoprofen Tramadol</keyword>
  <keyword>Dexketoprofen trometamol</keyword>
  <keyword>Tramadol hydrochloride</keyword>
  <keyword>Multimodal analgesia</keyword>
  <keyword>Third molar extraction</keyword>
  <keyword>Fixed drug combination</keyword>
  <keyword>Paracetamol</keyword>
  <keyword>Analgesics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Dexketoprofen trometamol</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

